Veritas (India) (512229)

FairStock Score: 8/100 — RISKY

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trailing P/E of 13.45 is not extreme if current earnings can stabilize.
• Latest quarter is profitable with ₹11 Cr net profit, not a loss.
• Quarterly revenue of ₹988 Cr shows a large trading/distribution scale.
• Stock at its 52-week high shows strong market interest and expectation of improvement.

Concerns

• ROE of 2.24% and ROCE of 5.35% are far too low to justify a P/B of 13.70.
• Sales have declined 39.86% and profits 63.65%, showing severe business deterioration.
• Piotroski F-Score of 3/9 and latest net margin of about 1.1% suggest fragile financial health.
• Dividend yield of 0.03% is negligible; promoter holding and debt/equity data are not disclosed.

AI Analysis

Let me start with the question I always ask: what kind of business am I buying, and what return is it generating on capital? Veritas (India) is a trading and distribution company. That business itself rarely gives me a durable moat unless it has unique contracts or pricing power—none of which I can see here. The price is ₹1,036, the market cap is ₹2,834 Cr, yet the company earns only 2.24% on equity and 5.35% on capital employed. Paying 13.7 times book value for that level of return is not value investing; it is hope. Benjamin Graham taught me to look for margin of safety. I see a high price and very thin margins of safety. The fundamentals are deteriorating. Sales fell 39.86% and profit fell 63.65%. The latest quarter shows ₹988 Cr of revenue but only ₹11 Cr of net profit—a margin of barely 1.1%. The Piotroski F-Score of 3/9 reinforces weak financial health. Dividend yield is 0.03%, so shareholders are not being paid to wait. The trailing P/E of 13.45 looks reasonable, but earnings are collapsing, and the stock's 52-week range of ₹132.20 to ₹1,036.00 tells me the market has already priced in a turnaround that the numbers do not yet confirm. FairStock Score of 7/100 says risky, and I agree. Promoter holding and debt/equity are not available, so I cannot judge governance or leverage properly. This is a speculative turnaround at a premium price, not a Graham-style bargain. I would wait on the sidelines until the business itself proves recovery and the price offers real value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer